Orbotech Develops Breakthrough Laser Direct Imaging System for HDI, Flex and Rigid-Flex Mass Production
22 Outubro 2009 - 8:17AM
Business Wire
ORBOTECH LTD. (NASDAQ/GSM SYMBOL: ORBK) today announced the
introduction of its new Paragon™-Xpress 9 Laser Direct Imaging
(LDI) system.
Designed for high speed throughput of up to 5,000 panels per day
per in-line solution, the Paragon-Xpress 9 is a breakthrough LDI
system for mass production, digital imaging of High Density
Interconnects (HDI), Flex and Rigid-Flex applications. Featuring
the same Large Scan Optics (LSO) Technology™ as Orbotech’s
well-established Paragon LDI family, the automated Paragon-Xpress 9
is now able to offer higher imaging accuracy and improved yields
and productivity on the most advanced volume jobs - faster and more
cost-effectively than was previously possible.
Commenting on the Paragon-Xpress 9 introduction, Mr. Hanan Gino,
President of the PCB Division at Orbotech Ltd., said: “Our latest
technological advancements in Paragon-Xpress 9 focus on boosting
Paragon LDI performance to meet high volume and speed requirements.
The system has already been field-proven in rigorous mass
production environments with excellent results. Being able to
achieve these throughput levels without having to compromise on
quality represents a crucial milestone in the progress of modern
PCB digital imaging and has opened the door to the widespread
utilization of LDI for HDI mass production.”
About Orbotech
Ltd.
Orbotech is principally engaged in the design, development,
manufacture, marketing and service of yield-enhancing and
production solutions for specialized applications in the supply
chain of the electronics industry. Orbotech’s products include
automated optical inspection (AOI), production and process control
systems for printed circuit boards (PCBs) and AOI, test and repair
systems for flat panel displays (FPDs). The Company also markets
computer-aided manufacturing and engineering (CAM) solutions for
PCB production. In addition, through its subsidiary, Orbograph
Ltd., the Company develops and markets character recognition
solutions to banks and other financial institutions, and has
developed a proprietary technology for web-based,
location-independent data entry for check processing and forms
processing; and, through its subsidiaries, Orbotech Medical Denmark
A/S and Orbotech Medical Solutions Ltd., is engaged in the research
and development, manufacture and sale of specialized products for
application in medical nuclear imaging. Of Orbotech’s employees,
more than one quarter are scientists and engineers, who integrate
their multi-disciplinary knowledge, talents and skills to develop
and provide sophisticated solutions and technologies designed to
meet customers’ long-term needs. Orbotech maintains its
headquarters and its primary research, development and
manufacturing facilities in Israel, and more than 30 offices
worldwide. Orbotech’s extensive network of marketing, sales and
customer support teams throughout North America, Europe, the
Pacific Rim, China and Japan deliver its knowledge and expertise
directly to customers the world over. For more information visit
www.orbotech.com.
Except for historical information, the matters discussed in this
press release are forward-looking statements within the meaning of
the U.S. Private Securities Litigation Reform Act of 1995. These
statements relate to, among other things, future prospects,
developments and business strategies and involve certain risks and
uncertainties. The words “anticipate,” “believe,” “could,” “will,”
“plan,” “expect” and “would” and similar terms and phrases,
including references to assumptions, have been used in this press
release to identify forward-looking statements. These
forward-looking statements are made based on management’s
expectations and beliefs concerning future events affecting
Orbotech and are subject to uncertainties and factors relating to
its operations and business environment, all of which are difficult
to predict and many of which are beyond the Company’s control. Many
factors could cause the actual results to differ materially from
those projected, including cyclicality in the industries in which
the Company operates, a sustained continuation or worsening of the
worldwide economic slowdown, the timing and strength of product and
service offerings by the Company and its competitors, changes in
business or pricing strategies, changes in the prevailing political
and regulatory framework in which the relevant parties operate or
in economic or technological trends or conditions, including
currency fluctuations, inflation and consumer confidence, on a
global, regional or national basis and other risks detailed in the
Company’s SEC reports, including the Company’s Annual Report on
Form 20-F for the year ended December 31, 2008. The Company assumes
no obligation to update the information in this press release to
reflect new information, future events or otherwise, except as
required by law.
Orbotech Ltd. - Ordinary Shares (NASDAQ:ORBK)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Orbotech Ltd. - Ordinary Shares (NASDAQ:ORBK)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024